Michael W. McCormick - 21 Feb 2023 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role
Director
Signature
/s/ Michael McCormick
Issuer symbol
CATX
Transactions as of
21 Feb 2023
Net transactions value
$0
Form type
4
Filing time
23 Feb 2023, 18:32:10 UTC
Previous filing
29 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CATX Stock Options (right to buy) Award $0 +470,000 +111% $0.000000 894,615 21 Feb 2023 Common Stock 470,000 $0.3800 Direct F1
transaction CATX Stock Options (right to buy) Award $0 +230,000 +26% $0.000000 1,124,615 21 Feb 2023 Common Stock 230,000 $0.3800 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vest monthly over three years.
F2 100% vests 2/21/2024.